BBIO stock news
This page provides real-time market news, earnings updates, and company announcements related to BridgeBio Pharma, Inc. (BBIO).
All content is aggregated from trusted financial media and market data sources to help investors stay informed about key market movements and corporate developments.
Last updated as of 2026-02-26 20:05 EST
Switzerland Postpones Crypto Tax Data Exchange to Meet Technological and International Requirements
Bitget-RWA2025-11-28 03:56:17
Kailera’s Ron Renaud discusses how a startup with connections to China can stand out in the obesity market
101 finance2026-01-20 12:09:29
BridgeBio Reports Positive Phase 3 Topline Results for Oral Infigratinib with the First Statistically Significant Improvements in Body Proportionality in Achondroplasia
Finviz2026-02-12 12:36:09
BridgeBio Nears 52-Week High On Strong Dwarfism Trial Data, Plans FDA Filing In 2026
Finviz2026-02-12 17:48:41
BBOT to Participate in Upcoming Investor Healthcare Conferences
Finviz2026-02-12 21:09:37
Bausch Health (BHC) Q4 Earnings Lag Estimates
Finviz2026-02-19 01:24:37
Blue Owl, Genuine Parts, And Okta Are Among Top 10 Large Cap Losers Last Week (Feb. 16-Feb. 20): Are the Others in Your Portfolio?
Finviz2026-02-22 15:03:41
BridgeBio Reports Fourth Quarter and Full Year 2025 Financial Results and Commercial Updates
Finviz2026-02-24 21:06:47
BridgeBio Pharma: Fourth Quarter Financial Highlights
101 finance2026-02-24 21:33:37
BridgeBio Pharma, Inc. announced that its investigational drug Encaleret for ADH1 (Autosomal Dominant Hypocalcemia Type 1) achieved positive results in the Phase 3 CALIBRATE clinical trial.
老虎证券2026-02-24 22:07:05
BBOT to Participate in Upcoming Investor Healthcare Conferences
Finviz2026-02-12 21:09:37
Bausch Health (BHC) Q4 Earnings Lag Estimates
Finviz2026-02-19 01:24:37
Blue Owl, Genuine Parts, And Okta Are Among Top 10 Large Cap Losers Last Week (Feb. 16-Feb. 20): Are the Others in Your Portfolio?
Finviz2026-02-22 15:03:41
BridgeBio Reports Fourth Quarter and Full Year 2025 Financial Results and Commercial Updates
Finviz2026-02-24 21:06:47
BridgeBio Pharma: Fourth Quarter Financial Highlights
101 finance2026-02-24 21:33:37
BridgeBio Pharma, Inc. announced that its investigational drug Encaleret for ADH1 (Autosomal Dominant Hypocalcemia Type 1) achieved positive results in the Phase 3 CALIBRATE clinical trial.
老虎证券2026-02-24 22:07:05
BBIO stock chart
BBIO stock detailsBBIO stock price change
On the last trading day, BBIO stock closed at 66.54 USD, with a price change of -2.59% for the day.
Trade stock perpsAbout Bitget
The world's first Universal Exchange (UEX), enabling users to trade not only cryptocurrencies, but also stocks, ETFs, forex, gold, and real-world assets (RWA).
Learn more